Unknown

Dataset Information

Spicae aetheroleum in uncomplicated acute bronchitis: a double-blind, randomised clinical trial.


ABSTRACT:

Background

The trial aimed to evaluate the efficacy and safety of Spicae aetheroleum (Spicae ae.), a phytomedicine obtained by steam distillation of the flowering tops of Lavandula latifolia, as compared to placebo in adult patients with acute bronchitis.

Methods

Patients with uncomplicated acute bronchitis (bronchitis severity score [BSS] ≥ 5 score points) were randomly assigned to treatment with Spicae ae. or placebo in a double-blind, parallel-group design. No additional treatment was admitted. The primary objective was the mean difference of a defined total BSS of 25% between the Spicae ae. and the placebo group after 7 days of full medication dose. Secondary endpoints included the BSS at day 10, additional signs and symptoms of bronchitis, quality of life (QoL) and safe

SUBMITTER: Kahler C 

PROVIDER: S-EPMC6435634 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature